文献速递疝与腹壁外科胃肠外科围术期管理与 ERAS

预防性补片位置与感染并发症:PRIMA试验再分析

Infectious Complication in Relation to the Prophylactic Mesh Position: The PRIMA Trial Revisited.
PubMed 文献 · J Am Coll Surg · 2021-02-15

该研究基于PRIMA随机试验数据,评估择期中线手术中预防性补片加强(onlay或sublay)与单纯缝合相比感染并发症的发生率、治疗及结局。结果显示补片组与缝合组感染并发症发生率无显著差异(13.9% vs 13.3%,p=0.821),但onlay组感染率高于sublay组(17.6% vs 10.3%,p=0.042);onlay补片合并感染的患者2年切口疝发生率显著高于无感染者(30.3% vs 9.7%,p=0.003)。

要点

  • 预防性补片不增加感染并发症发生率、严重程度或侵入性治疗需求。
  • onlay补片感染率高于sublay补片(17.6% vs 10.3%,p=0.042)。
  • onlay补片合并感染时切口疝风险显著升高(30.3% vs 9.7%,p=0.003)。

核心结论

  • 预防性补片置入与缝合关闭相比,不增加感染并发症的发生率、严重程度或侵入性治疗需求。
  • onlay补片加强患者发生感染并发症时,切口疝风险显著高于sublay组。

研究设计与样本

  • PRIMA随机试验的再分析,择期中线手术患者随机分为缝合关闭组、onlay补片组或sublay补片组。
  • 通过不良事件表评估感染并发症的发生率、治疗和结局,术后前瞻性收集数据2年。

主要发现

  • 总体感染并发症:缝合组14/107(13.3%),补片组52/373(13.9%),p=0.821。
  • onlay组感染并发症发生率17.6%,sublay组10.3%,p=0.042。
  • 排除吻合口漏原因后,onlay组16%,sublay组9.7%,p=0.073。
  • 52例感染并发症患者中40例(77%)补片可保留在位。
  • onlay补片加强后2年切口疝发生率:合并感染组10/33(30.3%),无感染组15/140(9.7%),p=0.003;sublay组差异无统计学意义。

关键数值与推荐

  • 预防性补片置入不增加感染并发症发生率、严重程度或侵入性治疗需求。
  • onlay补片感染率高于sublay补片(17.6% vs 10.3%,p=0.042)。
  • onlay补片合并感染时切口疝风险显著升高(30.3% vs 9.7%,p=0.003)。

临床怎么用

  • 择期中线手术预防性补片加强不增加感染并发症风险。
  • 选择onlay补片时需权衡感染后切口疝风险升高。
  • 多数感染并发症患者补片可保留在位(77%)。

局限性

  • 本研究为PRIMA试验的再分析,非预设终点分析。
  • 排除吻合口漏后onlay与sublay感染率差异未达统计学显著性(p=0.073)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prophylactic mesh reinforcement has proven to reduce the incidence of incisional hernia (IH). Fear of infectious complications may withhold the widespread implementation of prophylactic mesh reinforcement, particularly in the onlay position. STUDY DESIGN: Patients scheduled for elective midline surgery were randomly assigned to a suture closure group, onlay mesh group, or sublay mesh group. The incidence, treatment, and outcomes of patients with infectious complications were assessed through examining the adverse event forms. Data were collected prospectively for 2 years after the index procedure. RESULTS: Overall, infectious complications occurred in 14/107 (13.3%) patients in the suture group and in 52/373 (13.9%) patients with prophylactic mesh reinforcement (p = 0.821). Infectious complications occurred in 17.6% of the onlay group and 10.3% of the sublay group (p = 0.042). Excluding anastomotic leakage as a cause, these incidences were 16% (onlay) and 9.7% (sublay), p = 0.073. The mesh could remain in-situ in 40/52 (77%) patients with an infectious complication. The 2-year IH incidence after onlay mesh reinforcement was 10 in 33 (30.3%) with infectious complications and 15 in 140 (9.7%) without infectious complications (p = 0.003). This difference was not statistically significant for the sublay group. CONCLUSIONS: Prophylactic mesh placement was not associated with increased incidence, severity, or need for invasive treatment of infectious complications compared with suture closure. Patients with onlay mesh reinforcement and an infectious complication had a significantly higher risk of developing an incisional hernia, compared with those in the sublay group.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Van den Dop LM, Sneiders D, Kleinrensink GJ, et al. Infectious Complication in Relation to the Prophylactic Mesh Position: The PRIMA Trial Revisited. J Am Coll Surg. 2021. PMID: 33601004. doi:10.1016/j.jamcollsurg.2021.01.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。